The absence of Apoa1 could result in at least a 70% reduction in plasma HDL levels (Plump et al., 1997), which was a risk factor of atherogenic dyslipidemia and obesity. The gene discussed is APOA1; the disease is obesity due to melanocortin 4 receptor deficiency.